Is this imminent FDA feedback on the interim results from the mono therapy study or on the design protocol for the upcoming combined study with JAK inhibitor?
Is this imminent FDA feedback on the interim results from the...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $32.23M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $2.232K | 81.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 280000 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 297894 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| SNT (ASX) Chart |